Protein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases

被引:11
作者
Sipeki, S
Bander, E
Farkas, G
Gujdár, A
Ways, DK
Faragó, A
机构
[1] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1444 Budapest, Hungary
[2] E Carolina Univ, Dept Med, Div Endocrinol, Greenville, NC 27834 USA
基金
匈牙利科学研究基金会; 美国国家卫生研究院;
关键词
HGF; protein kinase C; Erk1/Erk2; MAP kinase cascade; cell scattering-associated protein; phosphatidylinositol; 3-kinase; c-Met; (HepG2 cells);
D O I
10.1016/S0898-6568(00)00105-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
HGF and phorbol ester induce the scattering of HepG2 cells. Recently, we have reported that the motility and morphological responses that accompany this process require the activation of Erk1/Erk2 MAP kinases, and phosphatidylinositol 3-kinase contributes to the activation of Erk1/Erk2 in HGF-induced cells. The cell scattering-associated appearance of a high-M-r (>300 kDa) protein pair has also been observed, and has been proven to be a sensitive marker of the intensity of Erk1/Erk2 activation. Our present study demonstrates that in HOP-induced cells protein kinase C and phosphatidylinositol 3-kinase regulate oppositely the expression of these cell scattering-associated proteins. While in phorbol ester-treated cells the sustained activation of protein kinase C is essential for this expression, in HGF-induced cells the inhibition of protein kinase C with bisindolylmaleimide I stimulates the expression. Protein kinase C reduces the HGF-induced phosphorylation of Erk1/Erk2, and in this way it can limit the intensity of Erk1/Erk2-dependent gene-expression (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 25 条
[1]   Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis [J].
Bardelli, A ;
Basile, ML ;
Audero, E ;
Giordano, S ;
Wennström, S ;
Ménard, S ;
Comoglio, PM ;
Ponzetto, C .
ONCOGENE, 1999, 18 (05) :1139-1146
[2]   Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase [J].
Birchmeier, C ;
Gherardi, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :404-410
[3]   Downstream signalling events regulated by phosphatidylinositol 3-kinase activity [J].
Duronio, V ;
Scheid, MP ;
Ettinger, S .
CELLULAR SIGNALLING, 1998, 10 (04) :233-239
[4]   PARTIAL DOWN-REGULATION OF PROTEIN-KINASE-C REVERSES THE GROWTH INHIBITORY EFFECT OF PHORBOL ESTERS ON HEPG2 CELLS [J].
DURONIO, V ;
HUBER, BE ;
JACOBS, S .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 145 (02) :381-389
[5]  
GANDINO L, 1990, ONCOGENE, V5, P721
[6]   DYNAMICS OF CADHERIN/CATENIN COMPLEX-FORMATION - NOVEL PROTEIN INTERACTIONS AND PATHWAYS OF COMPLEX ASSEMBLY [J].
HINCK, L ;
NATHKE, IS ;
PAPKOFF, J ;
NELSON, WJ .
JOURNAL OF CELL BIOLOGY, 1994, 125 (06) :1327-1340
[7]   Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1 [J].
Le Good, JA ;
Ziegler, WH ;
Parekh, DB ;
Alessi, DR ;
Cohen, P ;
Parker, PJ .
SCIENCE, 1998, 281 (5385) :2042-2045
[8]   Liver regeneration [J].
Michalopoulos, GK ;
DeFrances, MC .
SCIENCE, 1997, 276 (5309) :60-66
[9]   Differential effects of tyrosine kinase inhibitors and an inhibitor of the mitogen-activated protein kinase cascade on degranulation and superoxide production of human neutrophil granulocytes [J].
Mocsai, A ;
Banfi, B ;
Kapus, A ;
Farkas, G ;
Geiszt, M ;
Buday, L ;
Farago, A ;
Ligeti, E .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (07) :781-789
[10]   Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase [J].
Moriya, S ;
Kazlauskas, A ;
Akimoto, K ;
Hirai, S ;
Mizuno, K ;
Takenawa, T ;
Fukui, Y ;
Watanabe, Y ;
Ozaki, S ;
Ohno, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :151-155